Skip Page Header

Home > Nalbuphine (Nubain): Non-prescribed use, injecting, and risk behaviors for bloodborne viruses.

Connolly, Dominic and McElrath, Karen (2007) Nalbuphine (Nubain): Non-prescribed use, injecting, and risk behaviors for bloodborne viruses. Contemporary Drug Problems, 33, (2), pp. 321-340. https://doi.org/10.1177%2F009145090603300207.

[img]
Preview
PDF (Nalbuphine (Nubain): Non-prescribed use, injecting, and risk behaviors for bloodborne viruses)
903kB

Nalbuphine hydrochloride is a synthetic opiate with agonist-antagonist properties that has been prescribed for pain relief in several countries in North and Central America, Europe, and elsewhere. This drug has been marketed under the tradename NubainReg and was believed to have low potential for dependence. Previous research has noted misuse among bodybuilders, weightlifters, and users of anabolic steroids. This study examines patterns of nalbuphine misuse and injecting behaviours that pose risk for blood-borne viruses among ten respondents residing largely in one community in Ireland. Contrary to other research findings, most individuals had no history of weightlifting and no experience with the use of anabolic steroids. Most of the respondents had injected nalbuphine several times per day, and reported frequent injection of stimulants. Implications of the findings are discussed.


Item Type
Article
Publication Type
Irish-related, Open Access, Article
Drug Type
CNS stimulants, Opioid
Date
2007
Identification #
https://doi.org/10.1177%2F009145090603300207
Call No
BL, Northern Ireland
Page Range
pp. 321-340
Publisher
Federal Legal Publications Ltd
Volume
33
Number
2
EndNote
Accession Number
HRB 3709 (Electronic Only)
Related (external) link

Repository Staff Only: item control page